NI200900113A - CRYSTALLINE FORM OF 1- (Beta-D-GLUCOPYRANOSIL) -4-METHYL-3- [5- (4-FLUOROPHENYL) -2-THENYLMETHYL] BENZENE HEMIHYDRATE. - Google Patents

CRYSTALLINE FORM OF 1- (Beta-D-GLUCOPYRANOSIL) -4-METHYL-3- [5- (4-FLUOROPHENYL) -2-THENYLMETHYL] BENZENE HEMIHYDRATE.

Info

Publication number
NI200900113A
NI200900113A NI200900113A NI200900113A NI200900113A NI 200900113 A NI200900113 A NI 200900113A NI 200900113 A NI200900113 A NI 200900113A NI 200900113 A NI200900113 A NI 200900113A NI 200900113 A NI200900113 A NI 200900113A
Authority
NI
Nicaragua
Prior art keywords
fluorophenyl
beta
methyl
crystalline form
thenylmethyl
Prior art date
Application number
NI200900113A
Other languages
Spanish (es)
Inventor
Nomura Sumihiro
Kawanishi Eiji
Original Assignee
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp
Publication of NI200900113A publication Critical patent/NI200900113A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/04—Carbocyclic radicals

Abstract

Una forma cristalina novedosa del hemihidrato de 1-(Beta-D-glucopiranosil)-4-metil-3-[5-(4-fluorofenil)-2-tienilmetil]benceno, que tiene características favorables, se caracteriza por su patrón de difracción de rayos X de polvo y/o por su espectro infrarrojo.A novel crystalline form of 1- (Beta-D-glucopyranosyl) -4-methyl-3- [5- (4-fluorophenyl) -2-thienylmethyl] benzene hemihydrate, which has favorable characteristics, is characterized by its diffraction pattern X-ray powder and / or its infrared spectrum.

NI200900113A 2006-12-04 2009-06-04 CRYSTALLINE FORM OF 1- (Beta-D-GLUCOPYRANOSIL) -4-METHYL-3- [5- (4-FLUOROPHENYL) -2-THENYLMETHYL] BENZENE HEMIHYDRATE. NI200900113A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86842606P 2006-12-04 2006-12-04
JP2006327019 2006-12-04

Publications (1)

Publication Number Publication Date
NI200900113A true NI200900113A (en) 2010-11-29

Family

ID=50486662

Family Applications (1)

Application Number Title Priority Date Filing Date
NI200900113A NI200900113A (en) 2006-12-04 2009-06-04 CRYSTALLINE FORM OF 1- (Beta-D-GLUCOPYRANOSIL) -4-METHYL-3- [5- (4-FLUOROPHENYL) -2-THENYLMETHYL] BENZENE HEMIHYDRATE.

Country Status (3)

Country Link
HR (1) HRP20140254T4 (en)
NI (1) NI200900113A (en)
UA (1) UA93135C2 (en)

Also Published As

Publication number Publication date
HRP20140254T4 (en) 2021-10-29
HRP20140254T1 (en) 2014-04-25
UA93135C2 (en) 2011-01-10

Similar Documents

Publication Publication Date Title
AR118450A2 (en) CRYSTALLINE FORM OF 1- (b-D-GLUCOPYRANOSIL) -4-METHYL-3- [5- (4-FLUOROPHENYL) -2-THENYLMEthyl] BENZENE HEMIHYDRATE
CU23774A3 (en) ALFA-ENAC EXPRESSION ARNI INHIBITION
ATE545436T1 (en) USE OF THIOLATED POLYSACCHARIDES FOR TISSUE BUILDING
NI201001031A (en) CRYSTALLINE FORMS OF DIMETOXI DOCETAXEL AND METHOD TO PREPARE THE SAME.
UY30639A1 (en) SUBSTITUTED DERIVATIVES OF 2H-FTALAZIN-1-ONA, ITS CRYSTAL FORMS, PREPARATION PROCESS AND APPLICATIONS
BRPI0711889B8 (en) method for making simvastatin, composition of matter, method of making huvastatin, method of making simvastatin, and method of making a composition of matter of simvastatin or huvastatin
CL2008000585A1 (en) COMPOUNDS DERIVED FROM NICOTINAMIDE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT A DISEASE MEDIATED BY PROSTAGLANDIN D2 PRODUCED BY H-PGDS.
EA201101194A1 (en) APPLICATION OF ROSUVASTATIN LACTOL AS A MEDICINE PREPARATION
CL2011003009A1 (en) Process for the preparation of compounds derived from 4-phenyl-3,5- (thio) pyranodiones; intermediate compound; and preparation of said intermediary.
HRP20130561T1 (en) CRYSTALLISATION PROCESS FOR 1-(ß-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL]BENZENE
NI200900113A (en) CRYSTALLINE FORM OF 1- (Beta-D-GLUCOPYRANOSIL) -4-METHYL-3- [5- (4-FLUOROPHENYL) -2-THENYLMETHYL] BENZENE HEMIHYDRATE.
ATE526338T1 (en) ALKYL AND/OR ALKENYL ETHERS OF ALKYL AND/OR ALKENYL (POLY)GLYCOSIDS AND THEIR USE
CY1114969T1 (en) Crystalline form of 1- (β-D-glycopyranosyl) -4-methyl- 3- [5- (4-fluorophenyl) -2- thienylmethyl] benzene
WO2011033221A3 (en) Composition for the external treatment of cadavers
HN2009001135A (en) CRYSTALLINE SHAPE OF THE HEMIHYDRATE OF 1- (B-D-GLUCOPIRANOSIL) - 4-METHYL, 3- {5- (4-FLUOROPHENYL) -2-TIENYLMETIL} BENZENE
CL2007002359A1 (en) COMPOUNDS DERIVED FROM ARILPIPERAZINA; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT DEPRESSION, ANXIETY OR A COMBINATION OF BOTH.
MA33932B1 (en) DERIVATIVES OF 2-ALDOXIMINO-5-FLUOROPYRIMIDINE
HN2009003408A (en) ALFA-ENAC ARNI EXPRESSION INHIBITION
CL2010000016S1 (en) Section of a blind key.